The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure - Actions of permissive hormone

Clinical Nephrology

Volumn 64, Issue 2, 2005, Pages 98-102

  Cochran, M ^a   Coates, P T H ^b   Morris, H A ^c  

^a Endocrine and Bone Center   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c HANSON INSTITUTE   (Australia)

Author keywords

Calcitriol; Mild renal failure; Permissive effect

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITRIOL; CALCIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE; PHOSPHORUS; STEROID;

ADULT; AGED; ARTICLE; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MALE; OSTEOLYSIS; PREDICTION; RADIOIMMUNOASSAY; ULTRAFILTRATION; URINALYSIS;

EID: 23144452972     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64098     Document Type: Article

References (17)

1. Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR 1980 A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26: 562-567
2. Cochran M, Nordin BEC 1971 The causes of hypocalcemia in chronic renal failure. Clin Sci 40: 305-315
3. Cochran M, Bulusu L, Horsman A, Stasiak L, Nordin BEC 1973 Hypocalcemia and bone disease in renal failure. Nephron 10: 113-140
4. Cochran M 1993 Bone disease in renal failure In: Nordin BEC, Need AG, Morris HA (eds) Metabolic Bone and Stone Disease, 3rd edition, 1993. Churchill-Livingstone, Edinburgh, pp 164-165
5. +. Clin Chem 44: 1559-1562
6. Fraser D 1990 New concepts of vitamin D physiology. In: Stevenson JC (ed) New techniques in metabolic bone disease. 1990. Wright, London, pp 40-45
7. Kanis JA 1992 Hypercalcemia and hypocalcemia. In: Cameron S, Davison AM, Grunfeld J-P, Kerr DNS, Ritz E (eds) Oxford Textbook of Clinical Nephrology. Oxford University Press, New York 1992, pp 1754-1782
8. Massry SG, Coburn JW, Lee DBN, Jowsey J, Kleeman CA 1973 Skeletal resistance to PTH in renal failure. A study in 105 human subjects. Ann Int Med 78: 357-364
9. Massry SG 1976 Skeletal resistance to the calcemic action of PTH in uremia. Clin Endocrin 5 (Suppl): 317s-325s
10. Rboxyl-terminal ligands. Endocr Rev 2004 Nov 16; (Epub ahead of print)
11. Naik RB, Cundy T, Robinson BHB, Russell RGG, Kanis JA 1981 Effects of vitamin D metabolites and analogues on renal function. Nephron 28: 17-25
12. Puschett JB, Moranz J, Kunick WS 1972 Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium. J Clin Invest 51: 373-385
13. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L 1996 Comparison of biochemical markers of bone turnover in Paget's disease. J Bone Mineral Res 11: 1176-1184
14. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E 1991 Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrology, Dialysis and Transplantation 6: 1652-1653
15. 3 in response to PTH in patients with incipient renal failure. Nephron 57: 314-318
16. Szabo A, Ritz E, Schmidt-Gayk H, Reichel H 1996 Abnormal expression and regulation of vitamin D receptor in experimental uremia. Nephron 73: 619-628
17. Szabo A, Freesmeyer MG, Abenroth K, Stein G, Rosivall L, El-Shakmak A, Ritz E 1999 Physiological doses of calcium regulatory hormones do not normalize bone cells in uremic rats. Euro J Clin Invest 29: 466-468